
Having received both the CE mark in Europe and now also market clearance in Japan for the single-use gastroscope and display ecosystem, Ascope Gastro and Abox 2, the global product launch will be expanded to include Europe and Japan, Ambu has announced in a press release.
In February, Ambu received the US Food and Drug Administration’s clearance for the same products, and the medtech company is expecting to be able to announce further market expansions in Australia and Canada over the coming months.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app